Form D · Other Investment Fund
NGN Optiscan Fund II, L.P.
Stamford, CT · CIK 0001807947
Offering snapshot reported Mar 27, 2020 · SEC filing
- Reported sold
- $1.79M Offering amount: $1.79M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 4, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 27, 2020 | Initial | $1,794,187 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-363857
Source: Form D, filed Mar 27, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Ngn Bio Med I Gp, L.P. | Promoter |
| N/A Ngn Capital Llc | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
60 Long Ridge Road, Suite 402
Stamford, CT, 06902
Stamford, CT, 06902